Tuesday, February 02, 2021 1:35:15 PM
Sorry 2, part of GEM's moa is Liquidity. Their investments in NRX don't have that but RLF does. RLF has recently received another line of credit from GEM. The tide is raising, not ebbing here, IMHFO...
IMO, GEM will control the moves yet will continue to profit. I wont risk flipping some shares anymore just to keep up with them. GEM's ultimate expectation for RLF now is UP through several possible paths, IMO.
The RLF-100 Patent is the Jewel...GLTA...
IMO, GEM will control the moves yet will continue to profit. I wont risk flipping some shares anymore just to keep up with them. GEM's ultimate expectation for RLF now is UP through several possible paths, IMO.
The RLF-100 Patent is the Jewel...GLTA...
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
